Press Release: HELM AG sells HELM Medical GmbH subsidiary
Executive Director Pharma
Hamburg, Germany / 19 September 2017
The further development of HELM Medical GmbH is a priority within this transaction. For HELM AG a prerequisite of the negotiations was that Sanavita GmbH takes over the entire HELM Medical workforce and guarantees their jobs for three years.
Bernd Stoiber, Member of the HELM AG Executive Board and Executive Director Pharma, explains the decision: “The Pharma business unit has changed very significantly in recent years. Within this we became aware that there were less and less achievable synergies between the HELM Pharma business unit and HELM Medical. With the sale to Sanavita Pharmaceuticals GmbH we are ensuring that HELM Medical, with its specialisation in medical products, can develop further. I am very pleased that as a family company, Sanavita has very similar values to HELM and intends to develop both HELM Medical and its employees further.”
Describing the agreement, Frank Köhler, Sanavita Pharmaceuticals GmbH CEO, says: “We were convinced by HELM Medical GmbH’s service spectrum and product range. With this acquisition we are bringing in medical products that complement our existing portfolio very well. Sanavita already sells pharmaceutical products in many countries, and by acquiring HELM Medical we will now also be able to supply our partners with medical products. We are very much looking forward to working with our new colleagues, whose expertise will be a great contribution to Sanavita.”
HELM AG is a Hamburg-based family company established in 1900. In the 2016 financial year the Company generated global revenues of EUR 6.9 billion, making HELM one of the world’s largest chemicals marketing companies. The Company secures access to the world’s key markets through its specific regional knowledge and over 100 branches, Sales Offices and participations in over 30 countries. As a multifunctional marketing organisation HELM is active in the chemicals industry (Feedstocks and Derivatives), in the crop protection industry, in active pharmaceutical ingredients, pharmaceuticals, medical products, and in the fertilizer industry. HELM AG has a total of 1,495 employees.
Sanavita is part of Braun Beteiligungs GmbH, a family-managed company. Sanavita manufactures pharmaceutical products with market approval in a wide range of countries in the Near East, South Asia, Central Asia and Africa. In the 2016 financial year Braun Beteiligungs GmbH generated revenues of EUR 390 million and had around 1,000 employees.